The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade.

Dovedi, S J; Illidge, T M

Dovedi, S J; Illidge, T M.

Afiliação

Dovedi SJ; Targeted Therapy Group; Institute of Cancer Sciences; Manchester Cancer Research Center; University of Manchester; Manchester Academic Health Sciences Center ; Manchester, United Kingdom.
Illidge TM; Targeted Therapy Group; Institute of Cancer Sciences; Manchester Cancer Research Center; University of Manchester; Manchester Academic Health Sciences Center ; Manchester, United Kingdom.

Oncoimmunology ; 4(7): e1016709, 2015 Jul.

Article em En | MEDLINE | ID: mdl-26140246

Palavras-chave

IFN; PD-1 adaptive resistance; PD-L1; radiation; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google